Results 51 to 60 of about 869,634 (244)
Therapeutic antibodies under development for SARS‐CoV‐2
View, 2022 The world is experiencing one of the most difficult moments in history with COVID‐19, which has rapidly developed into a worldwide pandemic with a significant health and economic burden.
Zetong Ma +7 more
doaj +1 more source
Guillain‐Barré syndrome after SARS‐CoV‐2 infection
Journal of General and Family Medicine, 2022 We herein report a case of Guillain‐Barré syndrome (GBS) after SARS‐CoV‐2 infection. The patient was a close contact with a SARS‐CoV‐2 patient. Initially, she did not have any symptoms and quarantined at a hotel.
Mikiya Kajita +5 more
doaj +1 more source
A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology
Nature Microbiology, 2020 The ongoing pandemic spread of a new human coronavirus, SARS-CoV-2, which is associated with severe pneumonia/disease (COVID-19), has resulted in the generation of tens of thousands of virus genome sequences.
A. Rambaut +7 more
semanticscholar +1 more source
Aptamer‐based strategies against SARS‐CoV‐2 viruses
BMEMat, 2023 The COVID‐19 pandemic, caused by SARS‐CoV‐2, has seriously threatened human life and security in recent years and has had a serious impact on economic development. A range of strategies, including antibodies, small‐molecule agents and vaccines, have been
Yihao Huang +7 more
doaj +1 more source
Nature Communications, 2020 Since 2002, beta coronaviruses (CoV) have caused three zoonotic outbreaks, SARS-CoV in 2002–2003, MERS-CoV in 2012, and the newly emerged SARS-CoV-2 in late 2019. However, little is currently known about the biology of SARS-CoV-2.
Xiuyuan Ou +17 more
semanticscholar +1 more source
Molecular Crowding Modulates SARS‐CoV‐2 Aptamer Affinity
Small Structures, 2023 SARS‐CoV‐2 aptamer is a favorable candidate for the recognition and detection of SARS‐CoV‐2, owing to its small size and easy synthesis. However, the issue of compromised binding affinities in real samples and targeting mutant SARS‐CoV‐2 hinder wide ...
Ting Song +6 more
doaj +1 more source
Infectious Disease Clinics of North America, 2022 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in 2020 and has led to an unprecedented global pandemic. Understanding the virology behind SARS-CoV-2 infection has provided key insights into our efforts to develop antiviral agents and control the COVID-19 pandemic.
Li, Yijia, Li, Jonathan Z.
openaire +3 more sources
Evidence for Gastrointestinal Infection of SARS-CoV-2
Gastroenterology, 2020 The new coronavirus (SARS-CoV-2) outbreak originating from Wuhan, China, poses a threat to global health. While it's evident that the virus invades respiratory tract and transmits from human to human through airway, other viral tropisms and transmission ...
Fei Xiao +5 more
semanticscholar +1 more source
Monitoring of SARS‐CoV‐2 infection in mustelids
EFSA Journal, 2021 American mink and ferret are highly susceptible to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), but no information is available for other mustelid species.
European Food Safety Authority and European Centre for Disease Prevention and Control +14 more
doaj +1 more source
Nature Microbiology, 2020 Over the past 20 years, several coronaviruses have crossed the species barrier into humans, causing outbreaks of severe, and often fatal, respiratory illness. Since SARS-CoV was first identified in animal markets, global viromics projects have discovered
M. Letko, A. Marzi, V. Munster
semanticscholar +1 more source